Literature DB >> 33165684

Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.

Annika Jacob1, Wolfgang Albert1, Thomas Jackisch1, Christiane Jakob2, Anja Sims1, Helmut Witzigmann1, Sören Torge Mees1, Sigmar Stelzner3.   

Abstract

PURPOSE: Centralization of cancer care is expected to yield superior results. In Germany, the national strategy is based on a voluntary certification process. The effect of centre certification is difficult to prove because quality data are rarely available prior to certification. This observational study aims to assess outcomes for rectal cancer patients before and after implementation of a certified cancer centre. PATIENTS AND METHODS: All consecutive patients treated for rectal cancer in our certified centre from 2009 to 2017 were retrieved from a prospective database. The dataset was analyzed according to a predefined set of 19 quality indicators comprising 36 quality goals. The results were compared to an identical cohort of patients, treated from 2000 to 2008 just before centre implementation.
RESULTS: In total, 1059 patients were included, 481 in the 2009-2017 interval and 578 in the 2000-2008 interval. From 2009 to 2017, 25 of 36 quality goals were achieved (vs. 19/36). The proportion of anastomotic leaks in low anastomoses was improved (13.5% vs. 22.1%, p = 0.018), as was the local 5-year recurrence rate for stage (y)pIII rectal cancers (7.7% vs. 17.8%, p = 0.085), and quality of mesorectal excision (0.3% incomplete resections vs. 5.5%, p = 0.002). Furthermore, a decrease of abdominoperineal excisions was noted (47.1% vs. 60.0%, p = 0.037). For the 2009-2017 interval, local 5-year recurrence rate in stages (y)p0-III was 4.6% and 5-year overall survival was 80.2%.
CONCLUSIONS: Certification as specialized centre and regular audits were associated with an improvement of various quality parameters. The formal certification process has the potential to enhance quality of care for rectal cancer patients.

Entities:  

Keywords:  Anastomotic leak; Certified Colorectal Cancer Centre; Local recurrence rate; Quality indicators; Rectal cancer

Mesh:

Year:  2020        PMID: 33165684     DOI: 10.1007/s00384-020-03792-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  54 in total

Review 1.  [Criteria for evaluating prognostic factors].

Authors:  P Hermanek; U Mansmann
Journal:  Chirurg       Date:  2001-05       Impact factor: 0.955

2.  [S3-Guidelines Conference "Colorectal Carcinoma" 2004].

Authors:  W Schmiegel; C Pox; G Adler; W Fleig; U R Fölsch; P Frühmorgen; U Graeven; W Hohenberger; A Holstege; T Junginger; T Kühlbacher; R Porschen; P Propping; J F Riemann; R Sauer; T Sauerbruch; H J Schmoll; M Zeitz; H K Selbmann
Journal:  Z Gastroenterol       Date:  2004-10       Impact factor: 2.000

3.  [Uniform calculation of local recurrence rates--requirement for quality management in rectal carcinoma].

Authors:  Susanne Merkel; Ulrich Mansmann; Werner Hohenberger; Paul Hermanek
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2006

Review 4.  Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer.

Authors:  Nuh N Rahbari; Jürgen Weitz; Werner Hohenberger; Richard J Heald; Brendan Moran; Alexis Ulrich; Torbjörn Holm; W Douglas Wong; Emmanuel Tiret; Yoshihiro Moriya; Søren Laurberg; Marcel den Dulk; Cornelis van de Velde; Markus W Büchler
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

5.  [Quality indicators of diagnosis and therapy in MRI-based neoadjuvant radiochemotherapy for rectal cancer - interim analysis of a Prospective Multicentre Observational Study (OCUM)].

Authors:  R Ruppert; H Ptok; J Strassburg; C A Maurer; T Junginger; S Merkel; P Hermanek
Journal:  Zentralbl Chir       Date:  2012-06-14       Impact factor: 0.942

6.  MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial.

Authors:  Martin E Kreis; Reinhard Ruppert; Rainer Kube; Joachim Strassburg; Andreas Lewin; Joerg Baral; Christoph A Maurer; Joerg Sauer; Günther Winde; Rena Thomasmeyer; Sigmar Stelzner; Cornelius Bambauer; Soenke Scheunemann; Axel Faedrich; Theodor Junginger; Paul Hermanek; Susanne Merkel
Journal:  Ann Surg Oncol       Date:  2019-08-14       Impact factor: 5.344

Review 7.  [Quality indicators for diagnostic and therapy of rectal carcinoma].

Authors:  R Bittner; J Burghardt; E Gross; R T Grundmann; P Hermanek; C Isbert; T Junginger; F Köckerling; S Merkel; G Möslein; H-R Raab; J Roder; G Ruf; W Schwenk; J Strassburg; A Tannapfel; A de Vries; H Zühlke
Journal:  Zentralbl Chir       Date:  2007-04       Impact factor: 0.942

8.  Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial.

Authors:  R Ruppert; T Junginger; H Ptok; J Strassburg; C A Maurer; P Brosi; J Sauer; J Baral; M Kreis; D Wollschlaeger; P Hermanek; S Merkel
Journal:  Br J Surg       Date:  2018-05-09       Impact factor: 6.939

9.  [Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]

Authors:  Vinzenz Völkel; Teresa Draeger; Michael Gerken; Alois Fürst; Monika Klinkhammer-Schalke
Journal:  Gesundheitswesen       Date:  2018-04-19

10.  Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society.

Authors:  Christoph Kowalski; Ullrich Graeven; Christof von Kalle; Hauke Lang; Matthias W Beckmann; Jens-Uwe Blohmer; Martin Burchardt; Michael Ehrenfeld; Jan Fichtner; Stephan Grabbe; Hans Hoffmann; Heinrich Iro; Stefan Post; Anton Scharl; Uwe Schlegel; Thomas Seufferlein; Walter Stummer; Dieter Ukena; Julia Ferencz; Simone Wesselmann
Journal:  BMC Cancer       Date:  2017-12-14       Impact factor: 4.430

View more
  1 in total

Review 1.  [Low anterior resection syndrome-Causes and treatment approaches].

Authors:  Sigmar Stelzner; Juliane Kupsch; Sören Torge Mees
Journal:  Chirurg       Date:  2021-04-20       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.